Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma

International Journal of Surgical Oncology

Volumn 2014, Issue , 2014, Pages

  Hoang, Han L T ^a   Ensor, Kelsey ^b   Rosen, Gerald ^b   Leon Pachter, H ^a   Raccuia, Joseph S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; EPIDEMIOLOGY; FEMALE; FOLLOW UP; FORECASTING; HUMAN; HYSTERECTOMY; LEIOMYOSARCOMA; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; TRENDS; UNITED STATES; UTERINE NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; HYSTERECTOMY; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES; UTERINE NEOPLASMS;

EID: 84904212727     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2014/919323     Document Type: Article

References (26)

1. Leibsohn S., D'Ablaing G., Mishell D. R. Jr., Schlaerth J. B., Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. American Journal of Obstetrics and Gynecology 1990 162 4 968 976 2-s2.0-0025246266 (Pubitemid 20155415)
2. Kho K., Nezhat C., Evaluating the risks of electric uterine morecellation. The Journal of the American Medical Association 2014 311 905 906 10.1001/jama.2014.1093
3. Harlow B. L., Weiss N. S., Lofton S., The epidemiology of sarcomas of the uterus. Journal of the National Cancer Institute 1986 76 3 399 402 2-s2.0-0022572675 (Pubitemid 16119773)
4. Gadducci A., Landoni F., Sartori E., Zola P., Maggino T., Lissoni A., Bazzurini L., Arisio R., Romagnolo C., Cristofani R., Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecologic Oncology 1996 62 1 25 32 2-s2.0-0030200697 10.1006/gyno.1996.0185 (Pubitemid 26234541)
5. Salazar O. M., Bonfiglio T. A., Patten S. F., Keller B. E., Feldstein M., Dunne M. E., Rudolph J., Uterine sarcomas: natural history, treatment and prognosis. Cancer 1978 42 3 1152 1160 2-s2.0-0018122732 (Pubitemid 9054573)
6. Giuntoli R. L. II, Metzinger D. S., DiMarco C. S., Cha S. S., Sloan J. A., Keeney G. L., Gostout B. S., Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecologic Oncology 2003 89 3 460 469 2-s2.0-0037498554 10.1016/S0090-8258(03)00137-9 (Pubitemid 36687793)
7. Kapp D. S., Shin J. Y., Chan J. K., Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008 112 4 820 830 2-s2.0-39049114269 10.1002/cncr.23245 (Pubitemid 351240576)
8. Tropé C. G., Abeler V. M., Kristensen G. B., Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncologica 2012 51 6 694 705 2-s2.0-84863859812 10.3109/0284186X.2012.689111
9. Nam J.-H., Surgical treatment of uterine sarcoma. Best Practice and Research: Clinical Obstetrics and Gynaecology 2011 25 6 751 760 2-s2.0-80055026968 10.1016/j.bpobgyn.2011.05.009
10. Olah K. S., Dunn J. A., Gee H., Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. British Journal of Obstetrics and Gynaecology 1992 99 7 590 594 2-s2.0-0026635993
11. Prat J., FIGO staging for uterine sarcomas. International Journal of Gynecology and Obstetrics 2009 104 3 177 178 2-s2.0-66549090700 10.1016/j.ijgo.2008.12.008
12. Seddon B. M., Davda R., Uterine sarcomas-recent progress and future challenges. European Journal of Radiology 2011 78 1 30 40 2-s2.0-79954706262 10.1016/j.ejrad.2010.12.057
13. Loizzi V., Cormio G., Nestola D., Falagario M., Surgo A., Camporeale A., Putignano G., Selvaggi L., Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma. Oncology 2011 81 2 91 97 2-s2.0-80054888615 10.1159/000331679
14. Lusby K., Savannah K. B., Demicco E. G., Zhang Y., Ghadimi M. P., Young E. D., Colombo C., Lam R., Dogan T. E., Hornick J. L., Lazar A. J., Hunt K. K., Anderson M. L., Creighton C. J., Lev D., Pollock R. E., Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience. Annals of Surgical Oncology 2013 20 7 2364 2372 2-s2.0-84878856089 10.1245/s10434-012-2834-0
15. Lim D., Wang W. L., Lee C. H., Dodge T., Gilks B., Oliva E., Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases. Gynecologic Oncology 2013 128 2 322 326 2-s2.0-84872831621 10.1016/j.ygyno.2012.11.009
16. Gadducci A., Prognostic factors in uterine sarcoma. Best Practice and Research: Clinical Obstetrics and Gynaecology 2011 25 6 783 795 2-s2.0-80055041432 10.1016/j.bpobgyn.2011.06.002
17. Reed N. S., Mangioni C., Malmström H., Scarfone G., Poveda A., Pecorelli S., Tateo S., Franchi M., Jobsen J. J., Coens C., Teodorovic I., Vergote I., Vermorken J. B., Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). European Journal of Cancer 2008 44 6 808 818 2-s2.0-41849100978 10.1016/j.ejca.2008.01.019
18. Sutton G., Blessing J., Hanjani P., Kramer P., Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecologic Oncology 2005 96 3 749 752 2-s2.0-13844296902 10.1016/j.ygyno.2004.11.036 (Pubitemid 40255496)
19. Muss H. B., Bundy B., DiSaia P. J., Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer 1985 55 1648 1653 (Pubitemid 15103908)
20. Hensley M. L., Blessing J. A., Degeest K., Abulafia O., Rose P. G., Homesley H. D., Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecologic Oncology 2008 109 3 323 328 2-s2.0-44449135941 10.1016/j.ygyno.2008.02.024
21. Goff B. A., Rice L. W., Fleischhacker D., Muntz H. G., Falkenberry S. S., Nikrui N., Fuller A. F. Jr., Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecologic Oncology 1993 50 1 105 109 2-s2.0-0027279668 10.1006/gyno.1993.1172 (Pubitemid 23235520)
22. Leitao M. M., Brennan M. F., Hensley M., Sonoda Y., Hummer A., Bhaskaran D., Venkatraman E., Alektiar K., Barakat R. R., Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma. Gynecologic Oncology 2002 87 3 287 294 2-s2.0-0036930778 10.1006/gyno.2002.6840 (Pubitemid 36034649)
23. Giuntoli R. L. II, Garrett-Mayer E., Bristow R. E., Gostout B. S., Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecologic Oncology 2007 106 1 82 88 2-s2.0-34250186054 10.1016/j.ygyno.2007. 02.031 (Pubitemid 46901078)
24. Mantel N., Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 1966 50 3 163 170 2-s2.0-0013886333
25. Caceres A., Mourton S. M., Bochner B. H., Gerst S. R., Liu L., Alektiar K. M., Kardos S. V., Barakat R. R., Boland P. J., Chi D. S., Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. International Journal of Gynecological Cancer 2008 18 5 1139 1144 2-s2.0-51749121361 10.1111/j.1525-1438.2007.01140.x
26. Bernstein-Molho R., Grisaro D., Soyfer V., Safra T., Merimsky O., Metastatic uterine leiomyosarcomas: a single-institution experience. International Journal of Gynecological Cancer 2010 20 2 255 260 2-s2.0-77951887792 10.1111/IGC.0b013e3181c9e289